Results 1 to 10 of about 46,348 (289)
Predicting optical coherence tomography-derived diabetic macular edema grades from fundus photographs using deep learning [PDF]
Nature Communications, 2020 Diabetic eye disease is a cause of preventable blindness and accurate and timely referral of patients with diabetic macular edema is important to start treatment.
Avinash V. Varadarajan +17 more
doaj +4 more sources
Atypical Refractory Macular Edema: Are We Missing Something? [PDF]
Journal of Ophthalmic & Vision Research, 2022 Purpose: To report a case of bilateral refractory macular edema in a diabetic macular edema in a diabetic with an underlying systemic illness. Case Report: A 65-year-old male presented with the symptom of blurred vision in both eyes for three months.
Chaitra Jayadev +2 more
doaj +3 more sources
Microstructural Changes in the Macula Following Cataract Surgery in Patients with Type 2 Diabetes Mellitus Detected Using Optical Coherence Tomography Angiography [PDF]
Diagnostics, 2023 Background. Ophthalmologists treat diabetic macular edema before cataract surgery to reduce possible complications. Despite improvements in diagnostic techniques, whether cataract surgery per se causes the progression of diabetic retinopathy with macular
Lelde Svjaščenkova +2 more
doaj +3 more sources
Enzymatic vitreolysis for the treatment of tractional diabetic macular edema [PDF]
Therapeutic Advances in Ophthalmology, 2019 Background: A new approach to address focal vitreomacular adhesion in patients with diabetic macular edema may control and stabilize diabetic macular edema with fewer anti-vascular endothelial growth factor injections.
Bernardete Pessoa +7 more
doaj +3 more sources
Ophthalmology, 2012 Diabetic macular edema (DME) remains the most common cause of vision loss among diabetic patients. New understanding of the underlying pathophysiology has interest in the potential benefits of the specific pharmacologic therapy, such as treatment with intraocular steroids, anti-vascular endothelial growth factor (VEGF), and protein kinase C-beta (PKCβ)
Christina Antonopoulos +1 more
core +13 more sources
Indian Journal of Ophthalmology, 2006 Diabetic retinopathy is fast emerging as a leading cause of newly diagnosed legal blindness amongst the working population. Macular edema, as it is commoner, accounts for more vision impairment than neovascular proliferation in diabetic patients.
Vedantham Vasumathy, Kim Ramasamy
doaj +2 more sources
Alpha-Lipoic Acid for the Prevention of Diabetic Macular Edema [PDF]
, 2011 Introduction: To evaluate the effect of alpha-lipoic acid (ALA) on the occurrence of diabetic macular edema. Methods: Randomized, double-blind, placebo-controlled, multicenter, multinational study. Patients were randomized to the treatment group with 600
Anselm Kampik +5 more
core +3 more sources
Corticosteroid Treatment in Diabetic Macular Edema [PDF]
Türk Oftalmoloji Dergisi, 2017 Diabetic macular edema is the most common cause of visual impairment in patients with diabetes mellitus. The pathogenesis of macular edema is complex and multifactorial.
Burcu Nurözler Tabakcı , Nurten Ünlü
doaj +3 more sources
Topical Interferon Alpha 2b in the Treatment of Refractory Diabetic Macular Edema [PDF]
Journal of Ophthalmic & Vision Research, 2020 Purpose: To report the efficacy of topical interferon alpha 2b in the treatment of refractory diabetic macular edema. Methods: In this retrospective interventional case series, five eyes of three individuals with diabetic macular edema resistant to
Arash Maleki +2 more
doaj +3 more sources
Predictive impact of serous retinal detachment in refractory diabetic macular edema [PDF]
BMC OphthalmologyBackground Anti-vascular endothelial growth factor (VEGF) drugs are the first-line treatment option for DME management. However, part of DME was refractory to anti-VEGF medicine.
Zhuo-hua Zhou +3 more
doaj +2 more sources